Ilmarinen Mutual Pension Insurance Co Sells 8,533 Shares of Veeva Systems Inc. $VEEV

Ilmarinen Mutual Pension Insurance Co trimmed its position in shares of Veeva Systems Inc. (NYSE:VEEV) by 27.1% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 23,000 shares of the technology company’s stock after selling 8,533 shares during the quarter. Ilmarinen Mutual Pension Insurance Co’s holdings in Veeva Systems were worth $5,134,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. GPS Wealth Strategies Group LLC grew its stake in Veeva Systems by 196.4% during the third quarter. GPS Wealth Strategies Group LLC now owns 83 shares of the technology company’s stock worth $25,000 after buying an additional 55 shares during the last quarter. Raiffeisen Bank International AG bought a new stake in Veeva Systems during the third quarter worth about $28,000. Board of the Pension Protection Fund bought a new stake in Veeva Systems during the fourth quarter worth about $27,000. Newbridge Financial Services Group Inc. grew its stake in Veeva Systems by 322.6% during the fourth quarter. Newbridge Financial Services Group Inc. now owns 131 shares of the technology company’s stock worth $29,000 after buying an additional 100 shares during the last quarter. Finally, Activest Wealth Management grew its stake in Veeva Systems by 3,175.0% during the fourth quarter. Activest Wealth Management now owns 131 shares of the technology company’s stock worth $29,000 after buying an additional 127 shares during the last quarter. 88.20% of the stock is owned by institutional investors.

Insider Transactions at Veeva Systems

In related news, Director Priscilla Hung sold 750 shares of the firm’s stock in a transaction dated Thursday, April 30th. The stock was sold at an average price of $155.64, for a total value of $116,730.00. Following the transaction, the director owned 3,253 shares in the company, valued at $506,296.92. This trade represents a 18.74% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 10.60% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

VEEV has been the topic of several research analyst reports. Wells Fargo & Company decreased their price objective on shares of Veeva Systems from $333.00 to $317.00 and set an “overweight” rating on the stock in a research note on Thursday, March 5th. Citigroup cut Veeva Systems from a “buy” rating to a “neutral” rating and decreased their target price for the stock from $291.00 to $176.00 in a report on Friday, April 10th. Royal Bank Of Canada decreased their target price on Veeva Systems from $330.00 to $275.00 and set an “outperform” rating on the stock in a report on Thursday, March 5th. Morgan Stanley increased their target price on Veeva Systems from $205.00 to $215.00 and gave the stock an “equal weight” rating in a report on Thursday, March 5th. Finally, William Blair restated an “outperform” rating on shares of Veeva Systems in a report on Tuesday, March 10th. Sixteen investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $276.52.

Veeva Systems Price Performance

VEEV opened at $173.97 on Friday. Veeva Systems Inc. has a one year low of $148.05 and a one year high of $310.50. The company’s 50 day simple moving average is $166.38 and its 200-day simple moving average is $199.77. The stock has a market capitalization of $28.42 billion, a P/E ratio of 32.16, a price-to-earnings-growth ratio of 0.73 and a beta of 0.92.

Veeva Systems (NYSE:VEEV) last released its quarterly earnings results on Wednesday, March 4th. The technology company reported $2.06 EPS for the quarter, beating the consensus estimate of $1.94 by $0.12. Veeva Systems had a net margin of 28.44% and a return on equity of 13.80%. The business had revenue of $835.95 million for the quarter, compared to analysts’ expectations of $810.95 million. During the same period in the prior year, the firm earned $1.74 earnings per share. Veeva Systems’s revenue was up 16.0% compared to the same quarter last year. Veeva Systems has set its FY 2027 guidance at 8.850- EPS and its Q1 2027 guidance at 2.130-2.14 EPS. As a group, analysts anticipate that Veeva Systems Inc. will post 6.45 EPS for the current year.

Veeva Systems News Summary

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Veeva announced that Kindeva, a global CDMO, is adopting Veeva Quality Cloud to unify sites on a single platform, which supports Veeva’s growth narrative and could boost future recurring software revenue. Why Veeva Systems (VEEV) Stock Is Up Today
• Positive Sentiment: Coverage highlighting Veeva versus IQVIA points to strong industry tailwinds from life sciences digitization, with Veeva viewed as benefiting from AI adoption and a premium business model. Veeva vs. IQVIA: Which Life Sciences Tech Stock Holds More Promise?
• Neutral Sentiment: Several articles previewed Wall Street’s key metric estimates for Veeva’s upcoming quarter, suggesting investors are watching whether the company can meet growth expectations, but these pieces did not include a new earnings surprise or guidance update. Unveiling Veeva (VEEV) Q1 Outlook: Wall Street Estimates for Key Metrics
• Neutral Sentiment: Veeva was also highlighted as a trending stock and covered in analyst-style writeups noting a “Moderate Buy” consensus, which supports attention on the name but does not by itself change fundamentals. Veeva Systems Inc. (NYSE:VEEV) Given Average Recommendation of “Moderate Buy” by Analysts

About Veeva Systems

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.